(Q40093200)

17 September 2017

1 reference

title

Beta-adrenergic blockade for survivors of acute myocardial infarction (English)

1 reference

17 September 2017

β-Adrenergic Blockade for Survivors of Acute Myocardial Infarction (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

13 August 2023

main subject

myocardial infarction

1 reference

W. H. Frishman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6142420

13 August 2023

C. D. Furberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6142420

13 August 2023

W. T. Friedewald

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6142420

13 August 2023

language of work or name

English

0 references

publication date

1 March 1984

1 reference

17 September 2017

29 March 1984

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6142420

full work available at URL

13 August 2023

http://content.nejm.org/cgi/content/abstract/310/13/830

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6142420

http://www.nejm.org/doi/pdf/10.1056/NEJM198403293101306

13 August 2023

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

The New England Journal of Medicine

13 August 2023

published in

1 reference

17 September 2017

volume

310

1 reference

17 September 2017

issue

13

1 reference

17 September 2017

page(s)

830-837

1 reference

beta-Adrenoceptor antagonists: new drugs and new indications

17 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results

13 August 2023

2

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Letter: Reduction of sudden Deaths after myocardial infarction

13 August 2023

4

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Long-term treatment with ?-blockers after myocardial infarction

13 August 2023

5

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results

13 August 2023

6

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study

13 August 2023

8

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Multicentre international study: supplementary report

13 August 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

13 August 2023

10

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial

13 August 2023

12

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Controlled trial of sotalol for one year after myocardial infarction

13 August 2023

13

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

A long-term prevention study with oxprenolol in coronary heart disease

13 August 2023

14

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction:the continuing controversy

13 August 2023

16

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Role of beta-adrenergic blockade in the therapy of patients with myocardial infarction

13 August 2023

17

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Should every survivor of a heart attack be given a beta-blocker? Part I. Evidence from clinical trials

13 August 2023

19

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Secondary prevention after myocardial infarction: A review of short-term acute phase trials

13 August 2023

21

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Secondary prevention after myocardial infarction: A review of long-term trials

13 August 2023

22

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Survivorship patterns in the posthospital phase of myocardial infarction

13 August 2023

23

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Risk stratification and survival after myocardial infarction

13 August 2023

24

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Prognostic value of exercise testing soon after myocardial infarction

13 August 2023

25

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Anticoagulation in myocardial infarction: Modem approach to an old problem

13 August 2023

27

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group

13 August 2023

28

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Prognosis of men after first myocardial infarction: mortality and first recurrence in relation to selected parameters

13 August 2023

31

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Factors influencing long-term prognosis after recovery from myocardial infarction—Three-year findings of the Coronary Drug Project

13 August 2023

32

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Prediction of cardiovascular deaths and non-fatal reinfarctions after myocardial infarction

13 August 2023

33

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Effects of catecholamines, exercise, and nitroglycerin on the normal and ischemic myocardium in conscious dogs

13 August 2023

34

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Mechanisms of ventricular arrhythmias associated with myocardial infarction

13 August 2023

35

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Effect of propranolol in myocardial infarction

13 August 2023

36

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Absence of prophylactic effect of propranolol in myocardial infarction

13 August 2023

38

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Trial of propranolol in acute myocardial infarction

13 August 2023

40

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia

13 August 2023

41

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Ventricular antiarrhythmic effects of beta-adrenergic blocking drugs: a review of mechanism and clinical studies

13 August 2023

46

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold

13 August 2023

47

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Myocardial infarct size. Part I. Basic considerations

13 August 2023

48

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Myocardial Metabolic Changes Related to Ventricular Fibrillation

13 August 2023

49

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias

13 August 2023

50

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial

13 August 2023

52

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Propranolol therapy for ventricular arrhythmias 2 months after acute myocardial infarction

13 August 2023

54

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Hydrodynamic compression of the right atrium: a new echocardiographic sign of cardiac tamponade

13 August 2023

56

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Newer concepts in the pathophysiology of ischemic heart disease

13 August 2023

58

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Myocardial infarct size. Part 2. Comparison of anti-infarct effects of beta-blockade, glucose-insulin-potassium, nitrates, and hyaluronidase

13 August 2023

59

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Altered hemoglobin-oxygen affinity with long-term propranolol therapy in patients with coronary artery disease

13 August 2023

61

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a β-adrenoreceptor blocker

13 August 2023

62

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Beta-adrenergic blocking agents after myocardial infarction: An undocumented need in patients at lowest risk

13 August 2023

68

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction

13 August 2023

72

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction

13 August 2023

73

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

An early intervention secondary prevention study with oxprenolol following myocardial infarction

13 August 2023

74

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

A comparative study of cardioselective beta-blockade and diazepam in patients wtih acute myocardial infarction and tachycardia.

13 August 2023

76

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

13 August 2023

British Heart Journal

77

47

189

Mcllmoyle

1982

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Reduction of Infarct Size with the Early Use of Timolol in Acute Myocardial Infarction

13 August 2023

79

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Prophylaxis with beta-blockers and the community

13 August 2023

81

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Effect of propranolol and prazosin on blood lipids. The Oslo Study

13 August 2023

82

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Effects of Alinidine, A Novel Bradycardie Agent, on Heart Rate and Blood Pressure in Man

13 August 2023

84

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Drug therapy: atenolol and timolol, two new systemic beta-adrenoceptor antagonists

13 August 2023

86

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Propranolol dosage, plasma concentration, and beta blockade

13 August 2023

88

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Propranolol in angina pectoris: comparison of therapy given two and four times daily

13 August 2023

89

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Propranolol given twice daily in hypertension

13 August 2023

90

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol

13 August 2023

92

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction

13 August 2023

94

1 reference

https://api.crossref.org/works/10.1056/NEJM198403293101306

13 August 2023

Identifiers

0 references

1 reference